Grant: Idea to Innovation
University of Saskatchewan
$10,000.00
Market assessment and feasibility study on fowl adenovirus (FAdV) vaccine in chicken
FY 2013-14
Summary
This is market assessment proposal for fowl adenovirus (FAdV) vaccine developed at the University of Saskatchewan. The vaccine was tested in the laboratory settings and is ready to move to the field trials. This assessment will help to evaluate the market size, identify key players and assess the customer's perception for a broad FAdV vaccine in order to build a market entry strategy for our novel FAdV vaccine.
Program
Idea to Innovation
Recipient
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
446977-2013
Name nom
Gomis, Susantha
Department département
Western College of Veterinary Medicine
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
10000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
505
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Veterinary pharmaceuticals
Area of application fr
Produits pharmaceutiques à usage vétérinaire
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
1
Application title
Market assessment and feasibility study on fowl adenovirus (FAdV) vaccine in chicken
Keyword
NSERC
Application summary
This is market assessment proposal for fowl adenovirus (FAdV) vaccine developed at the University of Saskatchewan. The vaccine was tested in the laboratory settings and is ready to move to the field trials. This assessment will help to evaluate the market size, identify key players and assess the customer's perception for a broad FAdV vaccine in order to build a market entry strategy for our novel FAdV vaccine.